Meridian Bioscience, Inc. (VIVO) Tops Q1 EPS by 1c
Get Alerts VIVO Hot Sheet
Price: $33.97 --0%
EPS Growth %: -100.0%
Financial Fact:
Net Sales: 47M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: -100.0%
Financial Fact:
Net Sales: 47M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q1 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $45.4 million versus the consensus estimate of $44.34 million.
Meridian Bioscience, Inc. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
Meridian Bioscience, Inc. reaffirmed FY2013 guidance.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- AptarGroup (ATR) Tops Q1 EPS by 11c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!